ArticleClinical & developmental immunology2012

Serum CEACAM1 Correlates with Disease Progression and Survival in Malignant Melanoma Patients.

Sapoznik Sivan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.